THE RISK ASSESSMENT OF THE RESIDUAL NEUROMUSCULAR BLOCKADE UNDER LAPAROSCOPIC OPERATIVE INTERVENTIONS

THE RISK ASSESSMENT OF THE RESIDUAL NEUROMUSCULAR BLOCKADE UNDER LAPAROSCOPIC OPERATIVE INTERVENTIONS

The risk degree of the residual curarization was identified for the tracheal extubation under laparoscopic intervention. It is shown by the quantitative neuromuscular monitoring and "total-blind" control under which recovery rate of the neuromuscular conduction and how soon on the operatio...

Full description

Bibliographic Details
Main Authors:	D. A. Kurenkov, E. M. Nikolaenko, S. Yu. Chizhevskaya, E. A. Evdokimov
Format:	Article
Language:	Russian
Published:	NEW TERRA Publishing House 2017-11-01
Series:	Вестник анестезиологии и реаниматологии
Subjects:	neuromuscular blockade residual curarization monitoring of neuromuscular conduction
Online Access:	https://www.vair-journal.com/jour/article/view/27

Similar Items

Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study
by: Gonzalo Domenech, et al.
Published: (2019-08-01)

Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center
by: Carron M, et al.
Published: (2016-02-01)

Comparison of neuromuscular blockade recovery co-administered with neostigmine and different doses of calcium gluconate: a randomized control trial
by: So Ron Choi, et al.
Published: (2021-03-01)

MONITORING OF VARIOUS TYPES OF NEUROMUSCULAR BLOCKADE
by: N. V. Chubchenko, et al.
Published: (2018-01-01)

Effect of pneumoperitoneum on the recovery from intense neuromuscular blockade by rocuronium in healthy patients undergoing laparoscopic surgery
by: Hong Soon Kim, et al.
Published: (2014-07-01)

A surgeon′s assessment of inadequate neuromuscular antagonism in a case of prolonged neuromuscular blockade
by: James J Lamberg, et al.
Published: (2013-01-01)

Use of protocol and evaluation of postoperative residual curarization incidence in the absence of intraoperative acceleromyography - Randomized clinical trial
by: Filipe Nadir Caparica Santos, et al.

The association between residual neuromuscular blockade (RNMB) and critical respiratory events: a prospective cohort study
by: Faraj K Alenezi, et al.
Published: (2021-05-01)

Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial
by: Iacopo Cappellini, et al.
Published: (2018-02-01)

A survey of the current use of neuromuscular blocking drugs among the Middle Eastern anesthesiologists
by: Abdelazeem Eldawlatly, et al.
Published: (2013-01-01)

Comparison of Operating Conditions, Postoperative Pain and Recovery, and Overall Satisfaction of Surgeons with Deep vs. No Neuromuscular Blockade for Spinal Surgery under General Anesthesia: A Prospective Randomized Controlled Trial
by: Seok Kyeong Oh, et al.
Published: (2019-04-01)

Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular blockade for laparoscopic surgery in China
by: Maodong Ren, et al.
Published: (2020-11-01)

Neuromuscular diseases and anesthesia
by: Antonijević Vesna, et al.
Published: (2018-01-01)

Neuromuscular blockade management in the critically Ill patient
by: J. Ross Renew, et al.
Published: (2020-05-01)

The effect of hand dominance on neuromuscular monitoring at the adductor pollicis muscle
by: Ji Seon Jeong, et al.
Published: (2013-07-01)

Neuromuscular blockade management in patients with COVID-19
by: Harold Chaves-Cardona, et al.
Published: (2021-08-01)

At therapeutic concentration bupivacaine causes neuromuscular blockade and enhances rocuronium-induced blockade
by: Ji Hyeon Lee, et al.
Published: (2012-05-01)

A multicenter survey on the use of neuromuscular blockade in Greece. Does the real-world clinical practice indicate the necessity of guidelines?
by: Chrysanthi Batistaki, et al.
Published: (2019-01-01)

Neuromuscular blockade in cardiac surgery: An update for clinicians
by: Hemmerling Thomas, et al.
Published: (2008-01-01)

Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives
by: Carron M, et al.
Published: (2017-12-01)

Sugammadex in antagonism of neuromuscular block in anesthesia: a clinical and economic profile
by: Viola Sacchi, et al.
Published: (2009-09-01)

Effects of different sugammadex doses on the train of four ratio recovery progression during rocuronium induced neuromuscular blockade in the rat phrenic nerve hemidiaphragm
by: Yong Beom Kim, et al.
Published: (2020-06-01)

Role of amino acid infusion in delayed recovery from neuromuscular blockers
by: Seema Kalra, et al.
Published: (2010-01-01)

Analysis of incidence of residue neuromuscular blockade for rocuronium and cisatracurium
by: Qing-Long Dong
Published: (2020-11-01)

Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study
by: Pedro Marcos Silva e Gonçalves, et al.
Published: (2021-01-01)

The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
by: Soon Ho Cheong, et al.
Published: (2015-12-01)

Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
by: Marie T. Aouad, et al.
Published: (2017-04-01)

Comparison of Train of Four Measurements with Kinemyography NMT DATEX and Accelerography TOFscan
by: Cyrus Motamed, et al.
Published: (2021-03-01)

The effect of high concentration of magnesium with ropivacaine, gentamicin, rocuronium, and their combination on neuromuscular blockade
by: Won Ji Rhee, et al.
Published: (2015-02-01)

Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial
by: Tom Schepens, et al.
Published: (2019-10-01)

Comparison of deep or moderate neuromuscular blockade for thoracoscopic lobectomy: a randomized controlled trial
by: Xiao-feng Zhang, et al.
Published: (2018-12-01)

Effects of sevoflurane and adenosine receptor antagonist on the sugammadex‐induced recovery from rocuronium‐induced neuromuscular blockade in rodent phrenic nerve–hemidiaphragm tissue specimens
by: Yong Beom Kim, et al.
Published: (2021-08-01)

The synergistic effect of gentamicin and clindamycin on rocuronium-induced neuromuscular blockade
by: Ji Hyeon Lee, et al.
Published: (2013-02-01)

Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports
by: Usha Gurunathan, et al.
Published: (2019-11-01)

Genetic Testing for BCHE Variants Identifies Patients at Risk of Prolonged Neuromuscular Blockade in Response to Succinylcholine
by: Zhu G, et al.
Published: (2020-09-01)

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
by: Tiffany Woo, et al.
Published: (2013-12-01)

Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review
by: Khawaja Rashid Hafeez, et al.
Published: (2018-07-01)

A Meta-Analysis on the Effect of Dexamethasone on the Sugammadex Reversal of Rocuronium-Induced Neuromuscular Block
by: Chang-Hoon Koo, et al.
Published: (2020-04-01)

Efecto del bloqueo neuromuscular sobre la monitorización biespectral en los niños críticamente enfermos
by: Eva Sanavia, et al.
Published: (2020-10-01)

Sugammadex: clinical development and practical use
by: Thomas Fuchs-Buder, et al.
Published: (2013-12-01)